Author

R. El Khoury

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

A. Bigot· 1 shared A. Jaber· 1 shared A. Vu Hong· 1 shared C. Gonzalez Ibanez· 1 shared D. Israeli· 1 shared E. Istvankova· 1 shared G. Brochier· 1 shared I. Richard· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Bigot

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DNA i-motif levels are overwhelmingly depleted in living human cells: insights from in-cell NMR.

P. Viskova, E. Istvankova, J. Rynes, S. Dzatko, T. Loja, M. Lenarcic Zivkovic, R. Rigo, R. El Khoury, I. Serrano-Chacon, M. J. Damha, C. Gonzalez Ibanez, J.-L. Mergny, S. Foldynova-Trantirkova, L. Trantirek

The paper uses in-cell NMR to study DNA i-motif formation in human cells, finding that i-motifs are rare and cell cycle-dependent.

bioRxiv · Oct 1, 2023 · PreprintBiophysics

Disease exacerbation by fibroblast inclusion in Duchenne Muscular Dystrophy MYOrganoids reveals limitations of microdystrophin therapeutic efficacy

L. Palmieri, L. Pili, A. Jaber, A. Vu Hong, M. Marcello, R. El Khoury, G. Brochier, A. Bigot, D. Israeli, I. Richard, S. Albini

This paper develops a human DMD model using MYOrganoids to study fibroblast inclusion effects and evaluates microdystrophin therapy efficacy, finding limited success in reducing fibrosis and improving membrane stability.

bioRxiv · Jul 26, 2023 · PreprintBioengineering